| Literature DB >> 26029495 |
Satish Ramalingam1, Dharmalingam Subramaniam1, Shrikant Anant1.
Abstract
Small non-coding RNA has been implicated in the control of various cellular processes such as proliferation, apoptosis, and differentiation. About 50% of the miRNA genes are positioned in cancer-associated genomic regions. Several studies have shown that miRNA expression is deregulated in cancer and modulating their expression has reversed the cancer phenotype. Therefore, mechanisms to modulate microRNA (miRNA) activity have provided a novel opportunity for cancer prevention and therapy. In addition, a common cause for development of colorectal cancers is environmental and lifestyle factors. One such factor, diet has been shown to modulate miRNA expression in colorectal cancer patients. In this chapter, we will summarize the work demonstrating that miRNAs are novel promising drug targets for cancer chemoprevention and therapy. Improved delivery, increased stability and enhanced regulation of off-target effects will overcome the current challenges of this exciting approach in the field of cancer prevention and therapy.Entities:
Keywords: MiRNAs; drug delivery; nanoparticles; oncomiRs; phytochemicals; vitamins
Year: 2015 PMID: 26029495 PMCID: PMC4443920 DOI: 10.1007/s40495-015-0020-3
Source DB: PubMed Journal: Curr Pharmacol Rep ISSN: 2198-641X